EGFR-TKI-sensitive mutations in lung carcinomas: are they related to clinical features and CT findings?

References

• TorreLASiegelRLJemalALung Cancer Statistics.Adv Exp Med Biol201689311926667336
   PubMed Web of Science ®Google Scholar
• JännePAYangJCKimDWAZD9291 in EGFR inhibitor-resistant non-small-cell lung cancerN Engl J Med2015372181689169925923549
   PubMed Web of Science ®Google Scholar
• PaoWMillerVZakowskiMEGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProc Natl Acad Sci U S A200410136133061331115329413
   PubMed Web of Science ®Google Scholar
• PaezJGJännePALeeJCEGFR mutations in lung cancer: correlation with clinical response to gefitinib therapyScience200430456761497150015118125
   PubMed Web of Science ®Google Scholar
• GazdarAFPersonalized medicine and inhibition of EGFR signaling in lung cancerN Engl J Med2009361101018102019692681
   PubMed Web of Science ®Google Scholar
• LynchTJBellDWSordellaRActivating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinibN Engl J Med2004350212129213915118073
   PubMed Web of Science ®Google Scholar
• KosakaTYatabeYEndohHKuwanoHTakahashiTMitsudomiTMutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implicationsCancer Res200464248919892315604253
   PubMed Web of Science ®Google Scholar
• MitsudomiTKosakaTYatabeYBiological and clinical implications of EGFR mutations in lung cancerInt J Clin Oncol200611319019816850125
   PubMedGoogle Scholar
• ShigematsuHLinLTakahashiTClinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancersJ Natl Cancer Inst200597533934615741570
   PubMed Web of Science ®Google Scholar
• SheikineYRangachariDMcdonaldDCEGFR Testing in Advanced Non-Small-Cell Lung Cancer, A Mini-ReviewClin Lung Cancer201617648349227381270
   PubMed Web of Science ®Google Scholar
• YanoMSasakiHKobayashiYEpidermal growth factor receptor gene mutation and computed tomographic findings in peripheral pulmonary adenocarcinomaJ Thorac Oncol20061541341617409892
   PubMed Web of Science ®Google Scholar
• HsuKHChenKCYangTYEpidermal growth factor receptor mutation status in stage I lung adenocarcinoma with different image patternsJ Thorac Oncol2011661066107221512404
   PubMed Web of Science ®Google Scholar
• TomitaMAyabeTChosaEKawagoeKNakamuraKEpidermal growth factor receptor mutations in Japanese men with lung adenocarcinomasAsian Pac J Cancer Prev20141524106271063025605150
   PubMedGoogle Scholar
• YangYYangYZhouXEGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacityLung Cancer201587327227725582278
   PubMed Web of Science ®Google Scholar
• LeeHJKimYTKangCHEpidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypesRadiology2013268125426423468578
   PubMed Web of Science ®Google Scholar
• HsuJSHuangMSChenCYCorrelation between EGFR mutation status and computed tomography features in patients with advanced pulmonary adenocarcinomaJ Thorac Imaging201429635736325303964
   PubMed Web of Science ®Google Scholar
• BrinkmanGLCoatesEOThe effect of bronchitis, smoking, and occupation on ventilationAm Rev Respir Dis19638768469314015517
   PubMed Web of Science ®Google Scholar
• YangXLinDChanges of 2015 WHO Histological Classification of Lung Cancer and the Clinical SignificanceZhongguo Fei Ai Za Zhi201619633233627335291
   PubMedGoogle Scholar
• KimuraHFujiwaraYSoneTHigh sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patientsCancer Sci200697764264816827805
   PubMed Web of Science ®Google Scholar
• EllisonGDonaldEMcWalterGA comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samplesJ Exp Clin Cancer Res20102913220925915
   PubMed Web of Science ®Google Scholar
• TakamochiKNagaiKYoshidaJPathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findingsJ Thorac Cardiovasc Surg2001122232533011479506
   PubMed Web of Science ®Google Scholar
• IkeharaMSaitoHKondoTComparison of thin-section CT and pathological findings in small solid-density type pulmonary adenocarcinoma: prognostic factors from CT findingsEur J Radiol201281118919420965677
   PubMed Web of Science ®Google Scholar
• ChiuCHYangCTShihJYEpidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I MutationsJ Thorac Oncol201510579379925668120
   PubMed Web of Science ®Google Scholar
• BannoETogashiYNakamuraYSensitivities to various epidermal growth factor receptor-tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor-tyrosine kinase inhibitor?Cancer Sci201610781134114027240419
   PubMed Web of Science ®Google Scholar
• XuJJinBChuTEGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in ChinaLung Cancer201696879227133756
   PubMed Web of Science ®Google Scholar
• KobayashiYMitsudomiTNot all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategyCancer Sci201610791179118627323238
   PubMed Web of Science ®Google Scholar
• MokTSWuYLThongprasertSGefitinib or carboplatin-paclitaxel in pulmonary adenocarcinomaN Engl J Med20093611094795719692680
   PubMed Web of Science ®Google Scholar
• ZhouCWuYLChenGErlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 studyLancet Oncol201112873574221783417
   PubMed Web of Science ®Google Scholar
• LaiYZhangZLiJEGFR mutations in surgically resected fresh specimens from 697 consecutive Chinese patients with non-small cell lung cancer and their relationships with clinical featuresInt J Mol Sci20131412245492455924351833
   PubMed Web of Science ®Google Scholar
• LeeYJShimHSKangYADose effect of cigarette smoking on frequency and spectrum of epidermal growth factor receptor gene mutations in Korean patients with non-small cell lung cancerJ Cancer Res Clin Oncol2010136121937194420237940
   PubMed Web of Science ®Google Scholar
• SiegfriedJMWomen and lung cancer: does oestrogen play a role?Lancet Oncol20012850651311905727
   PubMed Web of Science ®Google Scholar
• HeQZhangMZhangJCorrelation between epidermal growth factor receptor mutations and nuclear expression of female hormone receptors in non-small cell lung cancer: a meta-analysisJ Thorac Dis2015791588159426543606
   PubMed Web of Science ®Google Scholar
• KhanEMLanirRDanielsonARGoldkornTEpidermal growth factor receptor exposed to cigarette smoke is aberrantly activated and undergoes perinuclear traffickingFaseb J200822391091717971399
   PubMed Web of Science ®Google Scholar
• GoldkornTFilostoSLung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smokeAm J Respir Cell Mol Biol201043325926820525802
   PubMed Web of Science ®Google Scholar
• UsudaKSagawaMMotonoNRelationships between EGFR mutation status of lung cancer and preoperative factors - are they predictive?Asian Pac J Cancer Prev201415265766224568474
   PubMedGoogle Scholar
• DoroshowJHTargeting EGFR in non-small-cell lung cancerN Engl J Med2005353220020216014890
   PubMed Web of Science ®Google Scholar
• SoneSSakaiFTakashimaSFactors affecting the radiologic appearance of peripheral bronchogenic carcinomasJ Thorac Imaging19971231591729249673
   PubMed Web of Science ®Google Scholar
• HanedaHSasakiHLindemanNA correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japa-nese patients with adenocarcinomaJpn J Clin Oncol2006362697516449241
   PubMed Web of Science ®Google Scholar
• TravisWDBrambillaENoguchiMInternational association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocar-cinomaJ Thorac Oncol20116224428521252716
   PubMed Web of Science ®Google Scholar
• OkimotoNAsaokaNFujitaKComputed tomography of lung cancer: frequency and characteristics of calcificationIntern Med200342990690714518688
   PubMed Web of Science ®Google Scholar
• KhanANAl-JahdaliHHAllenCMIrionKLAl GhanemSKoteyarSSThe calcified lung nodule: What does it mean?Ann Thorac Med201052677920582171
   PubMed Web of Science ®Google Scholar
• CaoYXuHA new predictive scoring system based on clinical data and computed tomography features for diagnosing EGFR-mutated lung adenocarcinomaCurr Oncol2018252132e138
   Web of Science ®Google Scholar
• GrewalRGAustinJHCT demonstration of calcification in carcinoma of the lungJ Comput Assist Tomogr19941868678717962791
   PubMed Web of Science ®Google Scholar
• MemonAAZhangHGuYEGFR with TKI-sensitive mutations in exon 19 is highly expressed and frequently detected in Chinese patients with lung squamous carcinomaOnco Targets Ther2017104607461329075127
   PubMed Web of Science ®Google Scholar
• OkadaMNishioWSakamotoTUchinoKTsubotaNDiscrepancy of computed tomographic image between lung and mediastinal windows as a prognostic implication in small lung adenocarcinomaAnn Thorac Surg20037661828183214667592
   PubMed Web of Science ®Google Scholar